Course contents

Low Dose Naltrexone Compounding

Pharmacists

Pharmaceutical Compounding

Welcome to our Expanding Your Book of Business Webinar series. This series is designed to educate pharmacists and other professionals on pertinent topics in the industry in a way that allows them to implement the knowledge gained and expand their business. In this installment we review clinical considerations and relevant literature pertaining to the use of low dose naltrexone (LDN), as well as compounding tips for working with low dose naltrexone.

 English only
  Pharmacists 
Write your awesome label here.

Why should I take this course?

  • Overview of Low Dose Naltrexone (LDN): Learn the basics of LDN and Discuss low dose vs ultra-low dose naltrexone (ULDN)
  • Benefits of LDN and ULDN and mechanisms of action in various conditions including: Autoimmune disorders, weight loss and pain.
  • Review compounding methods and formulations: Learn considerations for administration of naltrexone via various routes and in various types of dosage forms
  • Resources: Discover the available resources to help compounders better understand LDN and review relevant literature

Course Lesson

Meet your instructor

Linda Elsegood

Linda Elsegood is the CEO and founder of the LDN's Research Trust. At the age of 44, she was diagnosed with MS. After three years of relapsing/remitting MS and having attacks every 6 months, she was told she had secondary progressive and there was nothing anyone could do to help her.

She decided to take matters into her own hands and started taking low dose naltrexone in December 2003. After 3 months on LDN, she was told she no longer had secondary progressive MS, and she states, "LDN has given me a better quality of life and hope for the future."

With her success with LDN, she wanted everyone to hear about it as a treatment option. The LDN Research Trust became a UK registered non-profit charity in 2004. Since 2004, Linda has organized 7 conferences, started an LDN radio show, manages their social media channels, created 6 documentaries, and edited the LDN Book's 1 & 2.

The LDN Research Trust aims to initiate clinical trials of Low Dose Naltrexone for autoimmune diseases and cancers. The Trust has helped over 100,000 people all over the world obtain LDN.

Meet your instructor

Sarah Taylor, PharmaD

Sarah attended undergrad at St. Olaf College in Northfield where she majored in chemistry and worked in a lab synthesizing dendrimers for possible use as pharmaceutical delivery molecules. It was there that she first developed an interest in pharmacy. She graduated from St. Olaf and pursued her interest in pharmacy at the University of Minnesota College of Pharmacy. During school, she began working at a compounding pharmacy utilizing her chemistry and pharmacy background to develop formulas for a myriad of pharmaceutical dosage forms and applications. After graduation, she continued to work at the compounding pharmacy for a total of 5 years. She uses this experience to help with her current position as the manager of Fagron Academy. Her favorite types of compounds to make include tablet triturates and gummies.